tiprankstipranks
Trending News
More News >
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market

Kane Biotech (KNE) Financial Statements

Compare
1 Followers

Kane Biotech Financial Overview

Kane Biotech's market cap is currently C$8.17M. The company's EPS TTM is C$-0.004; its P/E ratio is -3.69; Kane Biotech is scheduled to report earnings on November 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 2.08MC$ 148.98KC$ 156.73KC$ 1.61MC$ 1.34M
Gross ProfitC$ 872.10KC$ 109.47KC$ 1.41MC$ 568.44KC$ 526.86K
Operating IncomeC$ -4.49MC$ -3.36MC$ -3.46MC$ -4.88MC$ -4.22M
EBITDAC$ -3.71MC$ -3.23MC$ -2.95MC$ -4.25MC$ -3.65M
Net IncomeC$ -3.02MC$ -5.03MC$ -3.89MC$ -4.60MC$ -3.72M
Balance Sheet
Cash & Short-Term InvestmentsC$ 358.81KC$ 749.25KC$ 1.10MC$ 1.15MC$ 1.01M
Total AssetsC$ 2.49MC$ 5.68MC$ 5.62MC$ 6.13MC$ 5.04M
Total DebtC$ 2.29MC$ 9.26MC$ 6.86MC$ 4.71MC$ 2.25M
Net DebtC$ 1.93MC$ 8.51MC$ 5.75MC$ 3.56MC$ 1.24M
Total LiabilitiesC$ 4.12MC$ 14.09MC$ 9.76MC$ 7.70MC$ 3.96M
Stockholders' EquityC$ -1.63MC$ -10.56MC$ -6.52MC$ -3.89MC$ -1.49M
Cash Flow
Free Cash FlowC$ -4.14MC$ -3.23MC$ -3.13MC$ -2.64MC$ -4.07M
Operating Cash FlowC$ -4.11MC$ -3.22MC$ -3.04MC$ -2.29MC$ -3.94M
Investing Cash FlowC$ 10.27MC$ -116.14KC$ -107.55KC$ -373.55KC$ -166.11K
Financing Cash FlowC$ -7.69MC$ 2.98MC$ 3.10MC$ 2.81MC$ 4.28M
Currency in CAD

Kane Biotech Earnings and Revenue History

Kane Biotech Debt to Assets

Kane Biotech Cash Flow

Kane Biotech Forecast EPS vs Actual EPS